Inventor · Lille, FR

Christophe De Romeuf

23Patents
4h-index
27Co-inventors
63Inventor score

Filing activity: Apr 12, 2001 → Apr 26, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8685725B2 Monoclonal antibodies with enhanced ADCC function Chemistry; Metallurgy 19 Active
US7931895B2 Monoclonal antibodies with enhanced ADCC function Chemistry; Metallurgy 19 Expired
US7579170B2 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII Chemistry; Metallurgy 17 Expired
US8501171B2 Use of ADCC-optimized antibodies for treating weak patients Emerging Cross-Sectional Technologies 6 Active
US9873745B2 Antibody method for treatment of a disease in which the target cells are cells which express CD20 Chemistry; Metallurgy 4 Active
US9234045B2 Monoclonal antibody directed against CD20 antigen Chemistry; Metallurgy 4 Active
US8409572B2 Monoclonal antibodies with enhanced ADCC function Chemistry; Metallurgy 3 Active
US8153124B2 Method for treating cancer using monoclonal antibodies Chemistry; Metallurgy 2 Active
US9546217B2 Recombinant anti-MUC1 antibodies Chemistry; Metallurgy 2 Active
US7790399B2 Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors Chemistry; Metallurgy 1 Expired
US9718890B2 Monoclonal antibodies with enhanced ADCC function Chemistry; Metallurgy 1 Active
US9708409B2 Monoclonal antibodies with enhanced ADCC function Chemistry; Metallurgy 1 Active
US8404241B2 Anti-rhesus D monoclonal antibody Chemistry; Metallurgy 0 Active
US8357370B2 Anti-D monoclonal antibodies Chemistry; Metallurgy 0 Active
US9879089B2 Use of ADCC-optimized antibodies for treating low-responder patients Emerging Cross-Sectional Technologies 0 Active
US8124078B2 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies Chemistry; Metallurgy 0 Active
US8178093B2 Method for treating infectious disease using monoclonal antibodies Chemistry; Metallurgy 0 Active
US12247076B2 Use of modified Fc fragments in immunotherapy Chemistry; Metallurgy 0 Active
US10081683B2 Monoclonal antibodies with enhanced ADCC function Chemistry; Metallurgy 0 Active
US8038993B2 Cytotoxic antibodies directed against antibodies inhibiting factor VIII Chemistry; Metallurgy 0 Active
US11649271B2 Fc mutants with modified functional activity Chemistry; Metallurgy 0 Active
US10239946B2 Cell line overexpressing human CD303 antigen Chemistry; Metallurgy 0 Active
US12291552B2 Chimeric protein in the treatment of amyloidosis Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.